Cambrex is a global market leader in branded and generic small molecule active pharmaceutical ingredients (APIs), advanced intermediates, custom development and manufacturing and controlled substances. Our pharmaceutical products, technologies and expertise accelerate your small molecule therapeutics into the market.

Type
Public
HQ
East Rutherford, US
Founded
1981
Size (employees)
1,228 (est)-5%
Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, US
Report incorrect company information

Cambrex Corporation Office Locations

Cambrex Corporation has an office in East Rutherford
East Rutherford, US (HQ)
1 Meadowlands Plaza
Show all (1)
Report incorrect company information

Cambrex Corporation Financials and Metrics

Cambrex Corporation Financials

Cambrex Corporation's revenue was reported to be $489.17 m in FY, 2016
USD

Revenue (Q1, 2018)

138.9 m

Gross profit (Q1, 2018)

48.7 m

Gross profit margin (Q1, 2018), %

35%

Net income (Q1, 2018)

24.1 m

EBIT (Q1, 2018)

30.4 m

Market capitalization (14-Jun-2018)

1.5 b

Closing share price (14-Jun-2018)

46.9

Cash (31-Mar-2018)

187.6 m
Cambrex Corporation's current market capitalization is $1.5 b.
Annual
USDFY, 2016

Revenue

489.2 m

Cost of goods sold

286.4 m

Gross profit

202.8 m

Gross profit Margin, %

41%
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018

Revenue

97.3 m80.6 m77.7 m106 m91.7 m93.4 m118.2 m99.3 m103.1 m112 m138.9 m

Cost of goods sold

64.5 m52.9 m48.4 m60.7 m57.3 m55.8 m70.1 m61.8 m58.2 m65.7 m90.2 m

Gross profit

32.9 m27.7 m29.3 m45.3 m34.4 m37.6 m48.1 m37.5 m44.9 m46.3 m48.7 m

Gross profit Margin, %

34%34%38%43%38%40%41%38%44%41%35%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

22.7 m45.5 m44 m74.1 m

Accounts Receivable

12.9 m10.6 m7.3 m6.7 m

Inventories

5.6 m8.7 m7.2 m123.2 m

Current Assets

202.6 m227.6 m259.3 m322.7 m
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018

Cash

62.6 m60.2 m85.6 m52.5 m90.7 m99.2 m118.4 m187.6 m

Accounts Receivable

8.1 m7.4 m9.6 m10.8 m7.4 m7.5 m81.8 m55.2 m

Inventories

127.1 m130.9 m131.6 m140.1 m143.9 m151.5 m5.1 m104.5 m

Current Assets

253.4 m246 m283.8 m279.9 m289 m332.8 m378.1 m462.7 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

25.9 m57.3 m57.2 m81.7 m

Depreciation and Amortization

22.5 m23.8 m22.1 m24.7 m

Inventories

(19 m)(9.1 m)(33 m)(23.7 m)

Accounts Payable

10.1 m12.4 m10.3 m1.8 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018

Net Income

20.6 m29.4 m8 m27.7 m39.4 m14.6 m35.1 m44.3 m19.9 m17.3 m24.1 m

Depreciation and Amortization

11.8 m17.9 m5.3 m10.7 m16.3 m5.6 m11.3 m17.7 m7.2 m7.5 m

Inventories

(16.5 m)(22.2 m)(29 m)(46.5 m)(52.5 m)(21 m)(35 m)(40.1 m)(28.2 m)5.1 m(58 k)

Accounts Payable

1.4 m8.1 m(2.2 m)2.7 m13.8 m4 m(12.4 m)(11.5 m)(10 m)39.9 m4.1 m
USDY, 2018

Financial Leverage

1.3 x
Show all financial metrics
Report incorrect company information